The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
T he first-ever needleless flu vaccine that can be given at home was just approved by the U.S. Food and Drug Administration.
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
The US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is ...